Increased nuchal translucency with normal karyotype

详细信息    查看全文

• 作者：Athena P. Souka ; Constantin S. von Kaisenberg ; Jonathan A. Hyett ; Jiri D. Sonek ; Kypros H. Nicolaides
• 关键词：Nuchal translucency ; Karyotype ; Genetic syndrome ; Structural anomaly ; Pathophysiology
• 刊名：American Journal of Obstetrics and Gynecology
• 出版年：2005
• 出版时间：April 2005
• 年：2005
• 卷：192
• 期：4
• 页码：1005-1021
• 全文大小：275 K

文摘

Increased fetal nuchal translucency (NT) thickness between 11 and 14 weeks' gestation is a common phenotypic expression of chromosomal abnormalities, including trisomy 21. However, even in the absence of aneuploidy, nuchal thickening is clinically relevant because it is associated with an increase in adverse perinatal outcome caused by a variety of fetal malformations, dysplasias, deformations, dysruptions, and genetic syndromes. Once the presence of aneuploidy is ruled out, the risk of perinatal outcome dose not statistically increase until the nuchal translucency measurement reaches 3.5 mm or more (>99th percentile). This increase in risk occurs in an exponential fashion as the NT measurement increases. However, if the fetus survives until midgestation, and if a targeted ultrasound at 20 to 22 weeks fails to reveal any abnormalities, the risk of an adverse perinatal outcome and postnatal developmental delay is not statistically increased.